Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 3
1988 1
1989 1
1990 3
1991 5
1992 7
1993 13
1994 12
1995 13
1996 28
1997 29
1998 33
1999 32
2000 51
2001 55
2002 80
2003 84
2004 112
2005 130
2006 151
2007 174
2008 190
2009 238
2010 243
2011 322
2012 309
2013 372
2014 408
2015 413
2016 441
2017 474
2018 521
2019 545
2020 553
2021 559
2022 440
2023 416
2024 149

Text availability

Article attribute

Article type

Publication date

Search Results

6,582 results

Results by year

Filters applied: . Clear all
Page 1
Fontan-Associated Dyslipidemia.
Lubert AM, Alsaied T, Palermo JJ, Anwar N, Urbina EM, Brown NM, Alexander C, Almeneisi H, Wu F, Leventhal AR, Aldweib N, Mendelson M, Opotowsky AR. Lubert AM, et al. J Am Heart Assoc. 2021 Apr 6;10(7):e019578. doi: 10.1161/JAHA.120.019578. Epub 2021 Mar 31. J Am Heart Assoc. 2021. PMID: 33787283 Free PMC article.
Pediatric Dyslipidemia-Beyond Familial Hypercholesterolemia.
Lazarte J, Hegele RA. Lazarte J, et al. Can J Cardiol. 2020 Sep;36(9):1362-1371. doi: 10.1016/j.cjca.2020.03.020. Epub 2020 Mar 23. Can J Cardiol. 2020. PMID: 32640212 Review.
To further stratify risk, determination of non-high-density lipoprotein cholesterol is recommended, for both its ability to predict ASCVD and convenience for the patient because fasting is not required. ...
To further stratify risk, determination of non-high-density lipoprotein cholesterol is recommended, for both its ability to predict A …
The new dyslipidemia guidelines: what is the debate?
Anderson TJ, Mancini GB, Genest J Jr, Grégoire J, Lonn EM, Hegele RA. Anderson TJ, et al. Can J Cardiol. 2015 May;31(5):605-12. doi: 10.1016/j.cjca.2014.11.007. Epub 2014 Nov 11. Can J Cardiol. 2015. PMID: 25816728 Review.
Comorbidities in unclassifiable interstitial lung disease.
Prior TS, Hyldgaard C, Torrisi SE, Kronborg-White S, Ganter C, Bendstrup E, Kreuter M. Prior TS, et al. Respir Res. 2022 Mar 16;23(1):59. doi: 10.1186/s12931-022-01981-3. Respir Res. 2022. PMID: 35296320 Free PMC article.
BACKGROUND: Comorbidities are common in interstitial lung diseases (ILD) and have an important association with survival, but the frequency and prognostic impact of comorbidities in unclassifiable interstitial lung disease (uILD) remains elusive. ...The cohort was dominate …
BACKGROUND: Comorbidities are common in interstitial lung diseases (ILD) and have an important association with survival, but the frequency …
Dyslipidemia Management in Adults With Diabetes.
Lazarte J, Hegele RA. Lazarte J, et al. Can J Diabetes. 2020 Feb;44(1):53-60. doi: 10.1016/j.jcjd.2019.07.003. Epub 2019 Jul 12. Can J Diabetes. 2020. PMID: 31521544 Review.
Association between Prescription and Control Status of Dyslipidemia and Hypertension among Japanese Patients with Diabetes.
Sakamoto M, Edo N, Takahashi S, Okamura E, Uno K, Morita K, Ishikawa T, Asahi K, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Kimura K, Ohashi Y, Watanabe T, Tsukamoto K. Sakamoto M, et al. J Atheroscler Thromb. 2019 Sep 1;26(9):805-820. doi: 10.5551/jat.47597. Epub 2019 Feb 6. J Atheroscler Thromb. 2019. PMID: 30726791 Free PMC article.
6,582 results